Infection Control. Infection Control. Goals & Objectives

Pages 20
Views 7

Please download to get full document.

View again

of 20
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Infection Control Goals & Objectives Course Description Infection Control is an online continuing education course for physical therapists and physical therapist assistants. This course presents updated
Infection Control Goals & Objectives Course Description Infection Control is an online continuing education course for physical therapists and physical therapist assistants. This course presents updated information about the management of infectious agents including sections on risks, precautions, transmission, intervention, and prevention. Course Rationale The purpose of this course is to present therapists and assistants with current information about the management of infectious agents. Course participants will use this information to effectively limit exposure and transmission of communicable pathogens among healthcare workers, patients, and other at-risk populations. Course Goals and Objectives Upon completion of this course, the therapist or assistant will be able to: 1. Differentiate and understand the three different modes of infectious agent transmission 2. Recognize infectious agents of special interest and understand the pathologies and challenges associated with these organisms. 3. Differentiate between the various categories of precautions, and know when each should be applied. 4. Identify transmission risks associated with different types of healthcare settings. 5. Identify transmission risks associated with special patient populations. 6. Recognize administrative measures used to prevent transmission of infectious agents. 7. Identify the appropriate use and purpose of each of the Personal Protective Equipment options. 8. Identify the practices utilized to prevent exposure to bloodborne pathogens. 9. Identify appropriate environmental measures, strategies and techniques used to prevent infectious agent transmission. 10. Recognize how to manage visitors to control infectious agent transmission. 11. Identify the precaution practices associated with specific pathogens. Course Provider Course Instructor - Michael Niss, DPT Target Audience - Physical therapists and physical therapist assistants Course Educational Level - This course is applicable for introductory learners. Course Prerequisites None Method of Instruction/Availability Online text-based course available continuously Criteria for issuance of CE Credits - A score of 70% or greater on the course post-test. Continuing Education Credits - Five (5) hours of continuing education credit 1 Infection Control Course Outline Page(s) Course Goals & Objectives 1 begin hour 1 Course Outline 2-3 Introduction 4 Transmission of Infectious Agents 4-10 Transmission Overview 4 Sources of Infectious Agents 5 Susceptible Hosts 5 Modes of Transmission 6-10 Contact Transmission 6-7 Droplet Transmission 7-8 Airborne Transmission 9-10 Other Sources of Infection 10 Infectious Agents of Special Infection Control Interest Clostridium difficile 11 Multidrug-Resistant Organisms (MDROs) end hour 1 Noroviruses begin hour 2 Acinetobacter 14 Hepatitis A Hepatitis B 15 Group A Strptococcus 16 Pseudomonas aeruginosa Respiratory Syncytial Virus (RSV) Hemorrhagic Fever Viruses (HFV) Severe Acute Respiratory Syndrome (SARS) Precautions to Prevent Transmission of Infectious Agents Standard Precautions end hour 2 Transmission-Based Precautions begin hour 3 Contact Precautions Droplet Precautions 25 Airborne Precautions Applications of Precautions 26 Discontinuation of Precautions Non-Inpatient Settings 27 Transmission Risks Specific to Type of Healthcare Settings Hospitals Intensive Care Units 28 Burn Units Pediatrics Non-acute Healthcare Settings Long-term Care Ambulatory Care Home Care 33 Other Healthcare Delivery Sites Transmission Risks of Special Patient Populations Immunocompromised Patients 34 Cystic Fibrosis Patients end hour 3 Therapies Associated with Transmissible Infectious Agents begin hour 4 Gene Therapy 35 Donation of Human Biological Products Xenotransplantation 36 2 Infection Control Course Outline (continued) Prevention of Transmission of Infectious Agents Administrative Measures Infection Control Professionals Safety Culture and Organizational Characteristics 38 Adherence to Recommended Guidelines Surveillance for Healthcare-Associated Infections (HAIs) Education of HCWs, Patients, and Families Hand Hygiene Personal Protective Equipment (PPE) Gloves Isolation Gowns 44 Face Protection Respiratory Protection end hour 4 Practices to Prevent Exposure to Bloodborne Pathogens begin hour 5 Prevention of Sharps-Related Injuries Prevention of Mucous Membrane Contact 48 Precautions During Aerosol-Generating Procedures Patient Placement Hospitals and Long-Term Care Settings Ambulatory Settings Home Care Transport of Patients 52 Environmental Measures Patient Care Equipment Textiles and Laundry 54 Solid Waste 55 Dishware and Eating Utensils 55 Adjunctive Measures Chemoprophylaxis Immunoprophylaxis 56 Management of Visitors 57 Visitors as Sources of Infection 57 Use of Barrier Precautions by Visitors 57 Precautions for Selected Infections and Conditions References 64 Post-Test end hour 5 3 Introduction Healthcare-associated infection (HAI) in the hospital is among the most common adverse events in healthcare. CDC estimates there are approximately 1.7 million healthcare-associated infections in U.S. hospitals and 99,000 associated deaths each year. There are approximately 4.5 infections per 100 hospital admissions, 9.3 infections per 1000 patient days in Intensive Care Units (ICUs), and 2 surgical site infections per 100 operations. These estimates are based on best available data, but some infections are known to be underreported, so the actual number of healthcare-associated infections may be higher. Estimates of the economic impact of healthcare-associated infections vary because of differences in how the data are defined and analyzed. Data from published studies indicate the estimated cost of healthcare-associated infection ranges from $10,500 per case for bloodstream, urinary tract, and pneumonia infections to $111,000 per case for antibiotic-resistant bloodstream infection in transplant patients. Healthcare-associated infections are defined as infections affecting patients who receive either medical or surgical treatments. The procedures and devices used to treat patients can also place them at increased risk for healthcare-associated infections. A patient's skin, the natural protection against bacteria entering the blood, is continually compromised by the insertion of needles and tubes to deliver life saving medicine. Microbial pathogens can be transmitted through tubes and devices that are going into patients, providing a pathway into the blood stream and lungs. Because of the number of procedures and the seriousness of patient conditions, patients treated in the ICU have the highest risk of healthcareassociated infections. The frequency of healthcare-associated infections varies by body site. In the United States from, the most frequent healthcare-associated infections reported to the National Nosocomial Infections Surveillance (NNIS) system, overall, were urinary tract infections (34%), followed by surgical site infections (17%), bloodstream infections (14%), and pneumonia (13%). Transmission Overview Transmission of Infectious Agents Transmission of infectious agents within a healthcare setting requires three elements: a source (or reservoir) of infectious agents, a susceptible host with a portal of entry receptive to the agent, and a mode of transmission for the agent. 4 Sources of Infectious Agents Infectious agents transmitted during healthcare derive primarily from human sources but inanimate environmental sources also are implicated in transmission. Human reservoirs include patients, healthcare personnel, and household members and other visitors. Such source individuals may have active infections, may be in the asymptomatic and/or incubation period of an infectious disease, or may be transiently or chronically colonized with pathogenic microorganisms, particularly in the respiratory and gastrointestinal tracts. The endogenous flora of patients (e.g., bacteria residing in the respiratory or gastrointestinal tract) also are the source of HAIs. Susceptible Hosts Infection is the result of a complex interrelationship between a potential host and an infectious agent. Most of the factors that influence infection and the occurrence and severity of disease are related to the host. However, characteristics of the host-agent interaction as it relates to pathogenicity, virulence and antigenicity are also important, as are the infectious dose, mechanisms of disease production and route of exposure. There is a spectrum of possible outcomes following exposure to an infectious agent. Some persons exposed to pathogenic microorganisms never develop symptomatic disease while others become severely ill and even die. Some individuals are prone to becoming transiently or permanently colonized but remain asymptomatic. Still others progress from colonization to symptomatic disease either immediately following exposure, or after a period of asymptomatic colonization. The immune state at the time of exposure to an infectious agent, interaction between pathogens, and virulence factors intrinsic to the agent are important predictors of an individuals outcome. Host factors such as extremes of age and underlying disease, human immunodeficiency virus/acquired immune deficiency syndrome, malignancy, and transplants can increase susceptibility to infection as do a variety of medications that alter the normal flora (e.g., antimicrobial agents, gastric acid suppressants, corticosteroids, antirejection drugs, antineoplastic agents, and immunosuppressive drugs). Surgical procedures and radiation therapy impair defenses of the skin and other involved organ systems. Indwelling devices such as urinary catheters, endotracheal tubes, central venous and arterial catheters and synthetic implants facilitate development of HAIs by allowing potential pathogens to bypass local defenses that would ordinarily impede their invasion and by providing surfaces for development of biofilms that may facilitate adherence of microorganisms and protect from antimicrobial activity. Some infections associated with invasive procedures result from transmission within the healthcare facility; others arise from the patient s endogenous flora. 5 Modes of Transmission Several classes of pathogens can cause infection, including bacteria, viruses, fungi, parasites, and prions. The modes of transmission vary by type of organism and some infectious agents may be transmitted by more than one route: some are transmitted primarily by direct or indirect contact, (e.g., Herpes simplex virus [HSV], respiratory syncytial virus, Staphylococcus aureus), others by the droplet, (e.g., influenza virus, B. pertussis) or airborne routes (e.g., M. tuberculosis). Other infectious agents, such as bloodborne viruses (e.g., hepatitis B and C viruses [HBV, HCV] and HIV are transmitted rarely in healthcare settings, via percutaneous or mucous membrane exposure. Importantly, not all infectious agents are transmitted from person to person. The three principal routes of transmission are summarized below. Contact Transmission The most common mode of transmission, contact transmission is divided into two subgroups: direct contact and indirect contact. Direct Contact Transmission - Direct transmission occurs when microorganisms are transferred from one infected person to another person without a contaminated intermediate object or person. Opportunities for direct contact transmission between patients and healthcare personnel include: blood or other blood-containing body fluids from a patient directly enters a caregiver s body through contact with a mucous membrane or breaks (i.e., cuts, abrasions) in the skin. mites from a scabies-infested patient are transferred to the skin of a caregiver while he/she is having direct ungloved contact with the patient s skin. a healthcare provider develops herpetic whitlow on a finger after contact with HSV when providing oral care to a patient without using gloves or HSV is transmitted to a patient from a herpetic whitlow on an ungloved hand of a healthcare worker (HCW). Indirect Contact Transmission - Indirect transmission involves the transfer of an infectious agent through a contaminated intermediate object or person. In the absence of a point-source outbreak, it is difficult to determine how indirect transmission occurs. However, extensive evidence suggests that the contaminated hands of healthcare personnel are important contributors to indirect contact transmission. Examples of opportunities for indirect contact transmission include: 6 Hands of healthcare personnel may transmit pathogens after touching an infected or colonized body site on one patient or a contaminated inanimate object, if hand hygiene is not performed before touching another patient. Patient-care devices (e.g., electronic thermometers, glucose monitoring devices) may transmit pathogens if devices contaminated with blood or body fluids are shared between patients without cleaning and disinfecting between patients. Shared toys may become a vehicle for transmitting respiratory viruses (e.g., respiratory syncytial virus) or pathogenic bacteria (e.g., Pseudomonas aeruginosa) among pediatric patients. Instruments that are inadequately cleaned between patients before disinfection or sterilization (e.g., endoscopes or surgical instruments) or that have manufacturing defects that interfere with the effectiveness of reprocessing may transmit bacterial and viral pathogens. Clothing, uniforms, laboratory coats, or isolation gowns used as personal protective equipment (PPE), may become contaminated with potential pathogens after care of a patient colonized or infected with an infectious agent, (e.g., MRSA, VRE, and C. difficile. Although contaminated clothing has not been implicated directly in transmission, the potential exists for soiled garments to transfer infectious agents to successive patients. Droplet Transmission Droplet transmission is, technically, a form of contact transmission, and some infectious agents transmitted by the droplet route also may be transmitted by the direct and indirect contact routes. However, in contrast to contact transmission, respiratory droplets carrying infectious pathogens transmit infection when they travel directly from the respiratory tract of the infectious individual to susceptible mucosal surfaces of the recipient, generally over short distances, necessitating facial protection. Respiratory droplets are generated when an infected person coughs, sneezes, or talks, or during procedures such as suctioning, endotracheal intubation, cough induction by chest physical therapy and cardiopulmonary resuscitation. Evidence for droplet transmission comes from epidemiological studies of disease outbreaks, experimental studies and from information on aerosol dynamics. Nasal mucosa, conjunctivae and less frequently the mouth, are susceptible portals of entry for respiratory viruses. The maximum distance for droplet transmission is currently unresolved, although pathogens transmitted by the droplet route have not been transmitted through the air over long distances, in contrast to the airborne pathogens discussed below. Historically, the area of defined risk has been a distance of 3 feet around the patient. Using this distance for donning masks has been effective in preventing transmission of infectious agents via the droplet route. However, experimental studies with 7 smallpox and investigations during the global SARS outbreaks of 2003 suggest that droplets from patients with these two infections could reach persons located 6 feet or more from their source. It is likely that the distance droplets travel depends on the velocity and mechanism by which respiratory droplets are propelled from the source, the density of respiratory secretions, environmental factors such as temperature and humidity, and the ability of the pathogen to maintain infectivity over that distance. Thus, a distance of 3 feet around the patient is best viewed as an example of what is meant by a short distance from a patient and should not be used as the sole criterion for deciding when a mask should be donned to protect from droplet exposure. Based on these considerations, it may be prudent to don a mask when within 6 to 10 feet of the patient or upon entry into the patient s room, especially when exposure to emerging or highly virulent pathogens is likely. More studies are needed to improve understanding of droplet transmission under various circumstances. Droplet size is another variable under discussion. Droplets traditionally have been defined as being 5 µm in size. Droplet nuclei, particles arising from desiccation of suspended droplets, have been associated with airborne transmission and defined as 5 µm in size, a reflection of the pathogenesis of pulmonary tuberculosis which is not generalizeable to other organisms. Observations of particle dynamics have demonstrated that a range of droplet sizes, including those with diameters of 30µm or greater, can remain suspended in the air. The behavior of droplets and droplet nuclei affect recommendations for preventing transmission. Whereas fine airborne particles containing pathogens that are able to remain infective may transmit infections over long distances, requiring AIIR to prevent its dissemination within a facility; organisms transmitted by the droplet route do not remain infective over long distances, and therefore do not require special air handling and ventilation. Examples of infectious agents that are transmitted via the droplet route include Bordetella pertussis, influenza virus, adenovirus, rhinovirus, Mycoplasma pneumoniae, SARS-associated coronavirus (SARS-CoV), group A streptococcus, and Neisseria meningitidis. Although respiratory syncytial virus may be transmitted by the droplet route, direct contact with infected respiratory secretions is the most important determinant of transmission and consistent adherence to Standard plus Contact Precautions prevents transmission in healthcare settings. Rarely, pathogens that are not transmitted routinely by the droplet route are dispersed into the air over short distances. For example, although S. aureus is transmitted most frequently by the contact route, viral upper respiratory tract infection has been associated with increased dispersal of S. aureus from the nose into the air for a distance of 4 feet under both outbreak and experimental conditions. 8 Airborne Transmission Airborne transmission occurs by dissemination of either airborne droplet nuclei or small particles in the respirable size range containing infectious agents that remain infective over time and distance (e.g., spores of Aspergillus spp, and Mycobacterium tuberculosis). Microorganisms carried in this manner may be dispersed over long distances by air currents and may be inhaled by susceptible individuals who have not had face-to-face contact with (or been in the same room with) the infectious individual. Preventing the spread of pathogens that are transmitted by the airborne route requires the use of special air handling and ventilation systems (e.g., AIIRs) to contain and then safely remove the infectious agent. Infectious agents to which this applies include Mycobacterium tuberculosis, rubeola virus (measles), and varicella-zoster virus (chickenpox). In addition, it is speculated that variola virus (smallpox) may be transmitted over long distances through the air under unusual circumstances and AIIRs are recommended for this agent as well; however, droplet and contact routes are the more frequent routes of transmission for smallpox. In addition to AIIRs, respiratory protection with NIOSH certified N95 or higher level respirator is recommended for healthcare personnel entering the AIIR to prevent acquisition of airborne infectious agents such as M. tuberculosis. For certain other respiratory infectious agents, such as influenza and rhinovirus, and even some gastrointestinal viruses
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks

We need your sign to support Project to invent "SMART AND CONTROLLABLE REFLECTIVE BALLOONS" to cover the Sun and Save Our Earth.

More details...

Sign Now!

We are very appreciated for your Prompt Action!